← Back
$ADPT All transactions

Adaptive Biotechnologies Corp

A

$ Value

$0

Shares

709,220

Price

$0

Filed

Mar 6

Insider

Name

ROBINS HARLAN S

Title

Chief Scientific Officer

CIK

0001780851

Roles

Officer

Transaction Details

Transaction Date

2026-03-06

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,992,324

Footnotes

Each performance share unit represents a contingent right to receive one share of the issuer's common stock. The performance share units were granted on March 6, 2023, with respect to the three-year period ending on March 6, 2026. The issuer certified the achievement of the performance goals on March 6, 2026. The performance share units vested on March 6, 2026.

Filing Info

Accession No.

0001780851-26-000005

Form Type

4

Issuer CIK

0001478320

ROBINS HARLAN S's History

Date Ticker Type Value
2026-04-08 ADPT $148K
2026-03-11 ADPT $1.9M
2026-03-11 ADPT $4.3M
2026-03-06 ADPT A $0
2026-03-04 ADPT A $0
2026-03-03 ADPT $235K
2026-03-02 ADPT $157K
2026-02-03 ADPT $154K
2026-02-02 ADPT $645K
2026-01-06 ADPT $164K

Other Insiders at ADPT (90d)

Insider Bought Sold Last
GRIFFIN MICHELLE RENEE $949K 2026-03-11
NEUPERT PETER M 2026-03-04
HERSHBERG ROBERT 2026-03-04
ROBINS CHAD M
CEO and Chairman
$18.6M 2026-04-08
LO FRANCIS
Chief People Officer
$1.3M 2026-04-08
PISKEL KYLE
Chief Financial Officer
$286K 2026-03-11
RUBINSTEIN JULIE
President and COO
$12.3M 2026-04-21
ROBINS HARLAN S
Chief Scientific Officer
$7.5M 2026-04-08
BENZENO SHARON
Chief Commercial Ofc Imm Med
$831K 2026-03-11
BOBULSKY SUSAN
Chief Commercial Officer, MRD
$544K 2026-03-11
OWEN KATEY EINTERZ 2026-03-04